✦ LIBER ✦

Adjuvant endocrine therapy in postmenopausal breast cancer patients

✍ Scribed by Dieter Köberle; Beat Thürlimann

Book ID: 113506698
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 148 KB
Volume: 14
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2005.08.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endocrine consequences of CMF adjuvant t

Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients

✍ Ann M. Dnistrian; Morton K. Schwartz; Alfred A. Fracchia; Richard J. Kaufman; Th 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 3 views

Target and reality of adjuvant endocrine

Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer

✍ Güth, U; Huang, D J; Schötzau, A; Zanetti-Dällenbach, R; Holzgreve, W; Bitzer, J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

Switching from tamoxifen to aromatase in

Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer

✍ C.J.H. van de Velde; S. Verma; J.G.H. van Nes; C. Masterman; K.I. Pritchard 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Cognitive function in postmenopausal bre

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

✍ Kelly-Anne Phillips; Julie Aldridge; Karin Ribi; Zhuoxin Sun; Alastair Thompson; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 241 KB

A randomized phase III trial of adjuvant

A randomized phase III trial of adjuvant endocrine therapy with tamoxifen for one year (TAM1) vs tamoxifen for two years (TAM2) in postmenopausal high risk patients with estrogen receptor positive or estrogen receptor unknown breast cancer. A DBCG study

✍ J. Andersen; M. Andersson; K.W. Andersen; P. Dombemowsky; H.T. Mouridsen; C. Ros 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Adjuvant therapy for postmenopausal wome

Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer

✍ Rachel A. Freedman; Eric P. Winer 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 195 KB